Summary

Patient preferences when using medicine is already part of the approval process for new medicines in FDA and EMA.

At this hot topic seminar, you gain an understanding of how patient involvement and patient preferences can be used to demonstrate the value of pharmaceutical products. You will hear, how a hospital doctor systematically has increased patient adherence through more patient involvement . You will also hear a representative from a pharmaceutical company present how they successfully made use of patient preferences to generate positive patient outcomes for a new innovative medicinal product. Last but least, the chairman of the Danish Medicines Council will present how they regard the use of such data in relation to strengthening a HTA application.

Keywords

• Patient preferences
• Patient Advocacy
• Patient involvement
• Medical Affairs
• HTA processes